For: | Xu SZ, Zhang XC, Jiang Q, Chen M, He MY, Shen P. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report. World J Clin Cases 2022; 10(28): 10236-10243 [PMID: 36246828 DOI: 10.12998/wjcc.v10.i28.10236] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i28/10236.htm |
Number | Citing Articles |
1 |
Alessandro Bonis, Andrea Dell’Amore, Vincenzo Verzeletti, Luca Melan, Giovanni Zambello, Chiara Nardocci, Giovanni Maria Comacchio, Federica Pezzuto, Fiorella Calabrese, Federico Rea. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases. Journal of Clinical Medicine 2023; 12(4): 1411 doi: 10.3390/jcm12041411
|
2 |
Kun Xu, Jin Gao, Lili Feng, Ying Fang, Xiuliang Tang. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1203876
|
3 |
Huijing Deng, Luyao Wang, Zewei Li, Tao Zhan, Liu Huang. Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12682-z
|
4 |
Sushree Subhadra Acharya, Chanakya Nath Kundu. Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment. Cancer Treatment Reviews 2024; 127: 102749 doi: 10.1016/j.ctrv.2024.102749
|